HI
EVLVW

HBK Investments’s Evolv Technologies Warrant EVLVW Stock Holding History

HBK Investments’s Portfolio EVLVW Stock Details EVLVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-55,000
Closed -$42K – 743
2021
Q4 		$42K Buy
+55,000
New +$64.8K ﹤0.01% 638

Other funds holding EVLVW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

HBK Investments's EVLVW Position: Q1 2022 in Review

HBK Investments sold out of Evolv Technologies Warrant (EVLVW) in Q1 2022, closing a stake of 55,000 shares — an estimated $42K sold.

HBK Investments first reported a position in EVLVW in Q4 2021 and held it in 1 quarter. The position peaked at $42K in Q4 2021. 13 funds tracked by Wall St. Rank hold EVLVW as of Q1 2022.

  • HBK Investments reported no remaining Evolv Technologies Warrant position as of Q1 2022 after selling out during the quarter.
  • HBK Investments sold 55,000 Evolv Technologies Warrant shares in Q1 2022, an estimated $42K.
  • HBK Investments first reported a position in Evolv Technologies Warrant in Q4 2021 and held it in 1 quarter.
  • HBK Investments's Evolv Technologies Warrant position peaked at $42K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Evolv Technologies Warrant as of Q1 2022.

Based on HBK Investments's 13F filing for Q1 2022, filed 16 May 2022.